We are a biotechnology company dedicated to developing treatments for certain medical conditions. Currently, two of our programs are focused on kidney disease that we believe have the potential to offer medical benefit.
$8.50 - $10.50
June 24, 2021
ROTH CAPITAL PARTNERS, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Unicycive Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277